Related Experiment Video
Updated: Jul 11, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
RET signaling in endocrine tumors: delving deeper into molecular mechanisms
Andrea Z Lai1, Taranjit S Gujral, Lois M Mulligan
1Division of Cancer Biology and Genetics, Cancer Research Institute, Queen's University, Botterell Hall Rm 329, Kingston, ON, K7L 3N6, Canada.
Abstract:
The rearranged during transfection (RET) proto-oncogene encodes a receptor tyrosine kinase that is implicated in the development of endocrine tumors of the thyroid and adrenal glands. In humans, activating RET mutations are found in the inherited cancer syndrome multiple endocrine neoplasia 2 and in sporadic medullary and papillary thyroid carcinomas. The specific type and location of RET mutations are strongly correlated with the disease phenotype and have both diagnostic and prognostic value. Recent advances in the molecular characterization of the RET receptor and its mutants have begun to define the mechanisms underlying the transforming ability of the different RET mutant forms. This information has revealed key functional features of these mutant proteins that distinguish the different clinically recognized mutations and provide clues as to the functional origins of the phenotypes associated with specific RET mutations. The elucidation of molecular mechanisms involved in RET-mediated transformation is a key step in the development of much needed therapeutics that target RET's oncogenic properties. Recent advances have begun to provide a deeper understanding of the receptor's function, and dysfunction, in human tumors that may guide this process.
Insights
Activating mutations in the rearranged during transfection (RET) gene drive endocrine tumor development. Understanding RET
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The rearranged during transfection (RET) proto-oncogene encodes a receptor tyrosine kinase.
- RET is implicated in endocrine tumors of the thyroid and adrenal glands.
- Activating RET mutations are found in multiple endocrine neoplasia 2 and sporadic thyroid carcinomas.
Purpose of the Study:
- To define the mechanisms underlying the transforming ability of different RET mutant forms.
- To understand the functional origins of phenotypes associated with specific RET mutations.
- To guide the development of therapeutics targeting RET's oncogenic properties.
Main Methods:
- Molecular characterization of the RET receptor and its mutants.
- Analysis of RET mutations in human endocrine tumors.
- Investigating the functional features of RET mutant proteins.
Main Results:
- Specific RET mutation types and locations correlate with disease phenotype, offering diagnostic and prognostic value.
- Key functional features distinguishing clinically recognized RET mutations have been identified.
- Insights into the functional origins of RET-associated phenotypes have been gained.
Conclusions:
- Understanding RET molecular mechanisms is crucial for developing targeted therapies.
- Advances in characterizing RET function and dysfunction in tumors can guide therapeutic strategies.
- Further research into RET's role in tumorigenesis is essential for clinical advancements.
Related Concept Videos
Endocrine Signaling
Endocrine Signaling
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

